On the recordJune 10, 2014
In a biosimilars provision in the Affordable Care Act, we gave 12 years of exclusivity to biologics.
Source
congress.govIn a biosimilars provision in the Affordable Care Act, we gave 12 years of exclusivity to biologics.
Waxman discusses exclusivity periods for biologics compared to small-molecule drugs.
Share
More from Henry Waxman
I think of how Henry Waxman showed America the true face of the tobacco industry, exposing decades of deceit.
The House's need for all the facts surrounding suspected Presidential offences cannot of course be circumscribed by an executive determination of what is relevant.
No Nation ever yet found any inconvenience from too close an inspection into the conduct of its officers.
The Federal Government would maintain its commitment to sharing the costs of providing basic healthcare and long-term coverage to vulnerable Americans.